These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2651054)

  • 1. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects.
    Paolisso G; Sgambato S; Pizza G; Passariello N; Varricchio M; D'Onofrio F
    Diabetes Care; 1989 Apr; 12(4):265-9. PubMed ID: 2651054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients.
    Paolisso G; Scheen A; Cozzolino D; Di Maro G; Varricchio M; D'Onofrio F; Lefebvre PJ
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1510-4. PubMed ID: 8200955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients.
    Paolisso G; Sgambato S; Giugliano D; Torella R; Varricchio M; Scheen AJ; D'Onofrio F; Lefèbvre PJ
    Diabetologia; 1988 Dec; 31(12):910-5. PubMed ID: 3071486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects.
    Paolisso G; Passariello N; Pizza G; Marrazzo G; Giunta R; Sgambato S; Varricchio M; D'Onofrio F
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):16-20. PubMed ID: 2662695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose iloprost infusion improves insulin action in aged healthy subjects and NIDDM patients.
    Paolisso G; Di Maro G; D'Amore A; Passariello N; Gambardella A; Varricchio M; D'Onofrio F
    Diabetes Care; 1995 Feb; 18(2):200-5. PubMed ID: 7537193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired insulin-mediated erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose diposal in aged non-diabetic obese patients.
    Paolisso G; Pizza G; De Riu S; Marrazzo G; Sgambato S; Varricchio M; D'Onofrio F
    Diabete Metab; 1990; 16(4):328-33. PubMed ID: 2265738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Alzaid AA; Dinneen SF; Moyer TP; Rizza RA
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1376-81. PubMed ID: 7714113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.
    Ferri C; Carlomagno A; Coassin S; Baldoncini R; Cassone Faldetta MR; Laurenti O; Properzi G; Santucci A; De Mattia G
    Diabetes Care; 1995 Feb; 18(2):226-33. PubMed ID: 7729302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily magnesium supplements improve glucose handling in elderly subjects.
    Paolisso G; Sgambato S; Gambardella A; Pizza G; Tesauro P; Varricchio M; D'Onofrio F
    Am J Clin Nutr; 1992 Jun; 55(6):1161-7. PubMed ID: 1595589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.
    Scheen AJ; Paolisso G; Salvatore T; Lefèbvre PJ
    Diabetes Care; 1991 Apr; 14(4):325-32. PubMed ID: 2060435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity.
    Yamanouchi K; Shinozaki T; Chikada K; Nishikawa T; Ito K; Shimizu S; Ozawa N; Suzuki Y; Maeno H; Kato K
    Diabetes Care; 1995 Jun; 18(6):775-8. PubMed ID: 7555502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
    Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
    Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
    Féry F; Balasse EO
    Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced glucose-induced thermogenesis is present in noninsulin-dependent diabetes mellitus without obesity.
    Gumbiner B; Thorburn AW; Henry RR
    J Clin Endocrinol Metab; 1991 Apr; 72(4):801-7. PubMed ID: 2005204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.